ScienHub
We enable the scientific community to achieve excellence
At ScienHub we offer comprehensive solutions for the implementation of clinical research and knowledge transfer. We accompany the scientific community in all phases of its specialized work, ensuring the quality and effectiveness of the results obtained.
Units
ScienHub in 2023
-
ScienHub in 2023
-
-
25 Apr 2024
Inmunoterapia en Dermatología 2024
-
Dermatology
-
On-site
-
Spanish
-
Casa Convalescència, Barcelona
18 May 2024
XXVII Jornada de l’Associació Catalana d’Uròlegs de Comarques
-
Urology
-
On-site
-
Catalan
-
Centre Cultural de Martorell
27 Jun
28 Jun 2024
The Barcelona Debates on the Human Microbiome 2024
-
Microbiome
-
On-site
-
English
-
Museo de la Ciencia CosmoCaixa
-
PostCROI: Up-to-date on HIV and other infections
03/04/2024
Dr. Eugènia Negredo presents at #PostCROI some of the latest updates on aging and HIV discussed at #CROI2024, such as the REPRIEVE study, the first large-scale study to test a strategy aimed at preventing heart disease among HIV-positive individuals. The results of this study are likely to prompt changes in clinics, as they have shown that HIV-positive individuals taking Pitavastatin have a lower risk of developing cardiovascular issues. This represents crucial information that influences clinical practice and HIV management.
-
SCHISTO-STOP Study Unveils Promising Results in Tackling Schistosomiasis
25/03/2024
The SCHISTO-STOP study, aimed at implementing a screening strategy for schistosomiasis in immigrant populations at epidemiological risk, reveals promising preliminary results. Schistosomiasis is one of the most common helminthic infections worldwide, with serious health implications. In Catalonia, it is estimated that over 17,000 individuals are infected, yet only a small fraction have been diagnosed. Despite the existing treatment, Praziquantel, being safe and effective with cure rates exceeding 90%, many cases go unnoticed. Collaborative efforts between researchers and teams at ScienHub Research Support have enabled the study to be concluded on time, yielding promising results that could influence global strategies to enhance the quality of life for this vulnerable population group.
-
The success of the PAX study: An example of coordination and efficiency in clinical research
15/03/2024
The PAX study consisted of a phase 2 clinical trial, randomized and double-blind, which prevented both the participant and the researcher from knowing which treatment the participant was receiving. This study has been one of the examples in which, thanks to the teamwork between the different departments of ScienHub Research Support and the good coordination of all parties involved, we have been able to meet the established deadlines and ensure good traceability of all data obtained.
-
ScienHub Research Support contributes to the development of HIPRA's COVID-19 vaccine in the EU
29/09/2023
ScienHub Research Support has played a key role in the clinical trials for the development of HIPRA’s vaccine, the first recombinant protein bivalent COVID-19 vaccine authorized in the European Union, ScienHub CTU has coordinated the implementation of the trials at the Germans Trias i Pujol Hospital site and has been the CRO responsable for the monitoring of one of HIPRA’s trials (RBDCOV project).